How much revenue does the computational pathology market generate?

The market size of computational pathology in 2027 is calculated to be USD 850.73 million.

What is the projected value of the computational pathology industry by 2036?

Computational Pathology Market size was valued at USD 785.68 million in 2026 and is anticipated to grow at a 9.75% CAGR from 2027 to 2036, attaining USD 1.99 billion by 2036.

How is the shift toward precision diagnostics accelerating computational pathology adoption?

Computational pathology provides detailed and reproducible analysis of tissue morphology, architecture, and biomarkers, supporting diagnosis, disease classification, and treatment selection as healthcare systems place greater emphasis on individualized care.

How are AI analytics and regulatory developments supporting clinical integration of computational pathology?

AI improves automated image analysis and pattern recognition, while clearer regulatory pathways provide confidence around validation, quality, interoperability, and patient safety, supporting integration into routine diagnostic workflows.

Why does machine learning lead the computational pathology technology market?

Machine learning accounted for 38.86% of the market in 2026, supported by its use in disease classification, image analysis, biomarker assessment, and diagnostic decision support across increasingly digitized pathology workflows.

How is computer vision expanding the computational pathology market?

Computer vision is the fastest-growing technology segment, driven by demand for automated tissue-image analysis, cellular quantification, lesion identification, and visual feature extraction that can support pathologists and improve workflow efficiency.

Why does North America lead the computational pathology market?

North America accounted for 48.12% of the market in 2026, supported by advanced healthcare infrastructure, established digital pathology capabilities, AI integration, and growing demand for precision medicine and data-driven diagnostics.

How is Asia Pacific creating new growth opportunities in computational pathology?

Asia Pacific is the fastest-growing region, driven by healthcare digitalization, investments in medical research, and increasing adoption of AI-based image analysis to improve pathology workflows, diagnostic capacity, and early disease detection.

Who holds a significant market share in the computational pathology landscape?

Major players in the computational pathology market include Philips (Netherlands), Leica Biosystems (Germany), Inspirata (Belgium), Proscia (USA), Roche (Switzerland), PathAI (USA), Indica Labs (USA), 3DHISTECH (Hungary), OptraSCAN (USA), Visiopharm (Denmark).